🇺🇸 Midodrine Hydrochloride Tablets in United States
28 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 23 April 2025 – 23 April 2026
- Total reports: 28
Most-reported reactions
- Drug Ineffective — 8 reports (28.57%)
- Dizziness — 3 reports (10.71%)
- Headache — 3 reports (10.71%)
- Asthenia — 2 reports (7.14%)
- Diarrhoea — 2 reports (7.14%)
- Dyspnoea — 2 reports (7.14%)
- Dysuria — 2 reports (7.14%)
- Hypotension — 2 reports (7.14%)
- Intentional Product Misuse — 2 reports (7.14%)
- Malaise — 2 reports (7.14%)
Other Cardiovascular approved in United States
Frequently asked questions
Is Midodrine Hydrochloride Tablets approved in United States?
Midodrine Hydrochloride Tablets does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Midodrine Hydrochloride Tablets in United States?
Tehran Heart Center is the originator. The local marketing authorisation holder may differ — check the official source linked above.